Hyperuricemia and Adverse Outcomes in Cardiovascular Disease
Clinical Potential of Advanced Glycation End-Product Inhibitors in Diabetes Mellitus
Immunosuppressive Therapy for Heart Failure
The Role of Lipids in the Development of Diabetic Microvascular Complications
Smoking Cessation for Patients with Cardiovascular Disease
ACE Inhibition with Moexipril
Assessment of Anti-Ischemic and Antianginal Effect at Trough Plasma Concentration and Safety of Trimetazidine MR 35mg in Patients with Stable Angina Pectoris
Spotlight on Abciximab in Patients with Ischemic Heart Disease Undergoing Percutaneous Coronary Revascularization1